Class summary at a glance.

Every drug in the Sympathomimetic Amine Anorectic class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $17447combined across class
Total Rx claims: 3K942 unique beneficiaries
Generic mfrs (active): 12across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Phentermine

Brand: LOMAIRA · 3K Part D claims (CY24) · 942 beneficiaries · First FDA approval: 1976-07-01

12 generic mfrs Discontinued

Low NADAC$0.070

→

Avg plan cost$0.113

Part D spend $17447 2× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.